Honghua H Jiang
Overview
Explore the profile of Honghua H Jiang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
229
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferdinand K, White W, Calhoun D, Lonn E, Sager P, Brunelle R, et al.
Hypertension
. 2014 Jul;
64(4):731-7.
PMID: 24980665
Glucagon-like peptide-1 receptor agonists, used to treat type 2 diabetes mellitus, are associated with small reductions in systolic blood pressure (SBP) and increases in heart rate. However, findings based on...
2.
Davidson J, Wolffenbuttel B, Arakaki R, Caballero A, Jiang H, Hardin D
Ethn Dis
. 2014 Jan;
23(4):393-400.
PMID: 24392599
Objective: To explore the impact of race/ethnicity on efficacy and safety of twice-daily insulin lispro mix 75/25 (LM75/25; 75% lispro protamine suspension, 25% insulin lispro) and once daily insulin glargine...
3.
Rees T, Curtis B, Gaskins K, Sierra-Johnson J, Jiang H, Liu R, et al.
Endocr Pract
. 2013 Dec;
20(5):389-98.
PMID: 24325997
Objective: To evaluate the efficacy and safety of insulin lispro in the treatment of patients with type 2 diabetes (T2DM) who had a body mass index (BMI) ≥30 kg/m2 (obese)...
4.
Jovanovic L, Peters A, Jiang H, Hardin D
Aging Clin Exp Res
. 2013 Oct;
26(2):115-21.
PMID: 24092662
Background And Aims: Few studies have evaluated long-term durability of glycemic control in older patients. The aim of this study was to compare durability of glycemic control of twice-daily insulin...
5.
Curtis B, Rees T, Gaskins K, Sierra-Johnson J, Liu R, Jiang H, et al.
Aging Clin Exp Res
. 2013 Aug;
26(1):77-88.
PMID: 23959960
Background And Aims: Glycemic control in geriatric patients with type 2 diabetes (T2DM) remains clinically challenging. The objective of this study was to compare the safety and efficacy of insulin...
6.
Wolffenbuttel B, Herman W, Gross J, Dharmalingam M, Jiang H, Hardin D
Diabetes Care
. 2013 Jun;
36(10):2931-6.
PMID: 23757434
Objective: Recent studies have reported hemoglobin A1c (HbA1c) differences across ethnic groups that could limit its use in clinical practice. The authors of the A1C-Derived Average Glucose study have advocated...
7.
Hardin D, Rohwer R, Curtis B, Zagar A, Chen L, Boye K, et al.
J Diabetes Sci Technol
. 2013 Apr;
7(2):420-30.
PMID: 23567001
Background: Treatment response in patients with type 2 diabetes mellitus (T2DM) varies because of different genotypic and phenotypic characteristics. Results of clinical trials are based largely on aggregated estimates of...
8.
Dungan K, Buse J, Herman W, Arakaki R, Jiang H, Jacobson J, et al.
Diabetes Res Clin Pract
. 2012 Mar;
96(3):e66-9.
PMID: 22421598
Endpoint HbA(1c) <7.0% was achieved by 80 (73.4%) lispro mix 25 (LM25)-treated patients and 67 (60.9%) glargine-treated patients (p=0.027) with baseline 1,5 anhydroglucitol (1,5AG) below median and 75 (70.8%) LM25-treated...
9.
de la Pena A, Riddle M, Morrow L, Jiang H, Linnebjerg H, Scott A, et al.
Diabetes Care
. 2011 Oct;
34(12):2496-501.
PMID: 21994429
Objective: Human regular U-500 (U-500R) insulin (500 units/mL) is increasingly being used clinically, yet its pharmacokinetics (PK) and pharmacodynamics (PD) have not been well studied. Therefore, we compared PK and...
10.
Herman W, Buse J, Arakaki R, Dungan K, Jiang H, Jacobson J, et al.
Endocr Pract
. 2011 May;
17(4):563-7.
PMID: 21550959
Objective: To compare outcomes in patients with type 2 diabetes initiating insulin lispro mix 75/25 (75% insulin lispro protamine suspension and 25% lispro) or insulin glargine therapy, stratified by baseline...